Trial Profile
Clinical Study on the Safety and Efficacy of CD19CART Cell Therapy for Refractory B-Cell Leukemia
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2018
Price :
$35
*
At a glance
- Drugs Anti cd19 CAR T cell therapy Innovative Cellular Therapeutics (Primary)
- Indications B-cell leukaemia; Lymphoid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 27 Feb 2018 New trial record